. iStock

Recommended Answer to gt biopharma phone number

GT Biopharma, Inc. (GTBP)

Immunotherapy for the Treatment of Cancer. Using our proprietary platform technology, GT Biopharma is generating novel immuno-oncology biopharmaceutical drugs ...

People Also Ask

gtbp stocktwits gt pharma why is gtbp stock dropping gtbp stock options gt biopharma pipeline gtbp stock forecast harpoon therapeutics

Popular Search Web Page

Contact. GT Biopharma, Inc. 8000 Marina Blvd Suite 100. Brisbane, CA 94005. First Name. Last Name. Email. Comments: Submit. GT Biopharma, Inc. Inc Logo.
Headquarters: 8000 Marina Blvd Ste 100, Brisbane, California, 94005, United States ; Phone Number: (415) 919-4040 ; Website: www.gtbiopharma.com ; Revenue: <$5 ...
SUB-INDUSTRY. Biotech & Pharma ; INCORPORATED. 10/15/1973 ; ADDRESS. 310 North Westlake Blvd Suite 206 Westlake Village, CA 91362 United States ; WEBSITE. www.
GT Biopharma, Inc. Biotechnology Research. Brisbane, California 608 followers. Focused on the next generation of immunotherapies by leveraging our proprietary ...
GT Biopharma Information ; Address, 9350 Wilshire Blvd, Ste 203, Beverly Hills, California 90212, US ; Phone, (310) 788-2850 ; Category, Drug Manufacturing & ...
Also Known As Oxis International ; Legal Name GT Biopharma, Inc. ; Stock Symbol OTCQB:GTBP ; Company Type For Profit ; Phone Number 310-860-5184.
SEC CIK #0000109657 ; State of Incorporation, DELAWARE ; Fiscal Year End, 12-31 ; Date of Edgar Filing Update, 2021-02-22 ; SIC, 2834 [PHARMACEUTICAL PREPARATIONS].
GT Biopharma, Inc. Overview ; 800-304-9888 · Biotech, Biotechnology · 8000 Marina Blvd, Brisbane, California, 94005 US 8000 Marina Blvd, Brisbane,... · 1-10 ...
Anthony J Cataldo is the Chairman of the Board at Gt Biopharma. You can contact Anthony at (800) 304-9888. Are ...

Disclaimer

All the information on the website is for reference only. If the user trades according to this information, he/she shall be responsible for any transaction loss. This website is not responsible for any errors in the content of the information or delay in updating.